- Markit via Yahoo FinanceApr 02 15:53 PM
This means that investors who seek to profit from falling equity prices are currently targeting MNK.
Mallinckrodt Reports Top-Line Results from Proof-of-Concept Study of Nitric Oxide Gas in Ex-Vivo System of Human Lung TransplantsMarket Watch3 days ago
- Zacks via Yahoo Finance5 days ago
Pain Management Market Fundamentals 2019: Latest Advancements Along with Growth Statistics, Current Trends And Restraints Forecast 2023Market Watch3 days ago
- Zacks via Yahoo FinanceApr 01 20:46 PM
Data from the study was consistent with the first three studies. Patients who received the 400 mg dose of SPN-812 daily, demonstrated a statistically significant improvement in ADHD rating scale ...
Exclusive: Pain-care specialist agrees to testify against Purdue, other drug makers - court documentsReuters via Yahoo FinanceApr 08 3:04 AM
A physician ally of Purdue Pharma LP whose views helped drive the explosive growth in the use of addictive pain relievers for common aches and pains in the United States has agreed to testify ...
- Zacks via Yahoo FinanceApr 09 13:15 PM
Kevin Matras, Kevin Cook, Dr. John Blank and Sheraz Mian will cover the investment landscape from several angles in this informative event. Read the full write-up for a lot more on COST.
- Zacks via Yahoo FinanceApr 15 14:50 PM
Mallinckrodt plc MNK announced that Stratatech (acquired in 2016) has completed enrollment in the phase III study on its investigational regenerative skin tissue, StrataGraft.